Controlled High-risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurologic Surveillance (CHAMPIONS10).
Phase of Trial: Phase III
Latest Information Update: 28 Oct 2017
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms CHAMPIONS; CHAMPS
- 28 Oct 2017 Results presented at the 7th Joint Congress of the European Committee for Treatment and Research in Multiple Sclerosis and Americas Committee for Treatment and Research in Multiple Sclerosis
- 20 Apr 2012 Results will be presented at the 64th Annual Meeting of the American Academy of Neurology (AAN-2012) according to a Biogen Idec media release.
- 05 Nov 2010 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History